Tracking 20 Years of Compound-to-Target Output from Literature and Patents
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tracking 20 Years of Compound-to-Target Output from Literature and Patents
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 10, Pages e77142
Publisher
Public Library of Science (PLoS)
Online
2013-10-30
DOI
10.1371/journal.pone.0077142
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BACE2 as a new diabetes target: a patent review (2010 – 2012)
- (2013) Christopher Southan EXPERT OPINION ON THERAPEUTIC PATENTS
- US presidential candidates diverge on how to help biopharma
- (2012) Susan Matthews NATURE MEDICINE
- 2011 FDA drug approvals
- (2012) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Diagnosing the decline in pharmaceutical R&D efficiency
- (2012) Jack W. Scannell et al. NATURE REVIEWS DRUG DISCOVERY
- Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass
- (2011) Daria Esterházy et al. Cell Metabolism
- Making every SAR point count: the development of Chemistry Connect for the large-scale integration of structure and bioactivity data
- (2011) Sorel Muresan et al. DRUG DISCOVERY TODAY
- What Do Medicinal Chemists Actually Make? A 50-Year Retrospective
- (2011) W. Patrick Walters et al. JOURNAL OF MEDICINAL CHEMISTRY
- Robust Central Reduction of Amyloid- in Humans with an Orally Available, Non-Peptidic -Secretase Inhibitor
- (2011) P. C. May et al. JOURNAL OF NEUROSCIENCE
- Getting pharmaceutical R&D back on target
- (2011) Mark E Bunnage Nature Chemical Biology
- US academic drug discovery
- (2011) Stephen Frye et al. NATURE REVIEWS DRUG DISCOVERY
- The influence of the 'organizational factor' on compound quality in drug discovery
- (2011) Paul D. Leeson et al. NATURE REVIEWS DRUG DISCOVERY
- The productivity crisis in pharmaceutical R&D
- (2011) Fabio Pammolli et al. NATURE REVIEWS DRUG DISCOVERY
- Impact of high-throughput screening in biomedical research
- (2011) Ricardo Macarron et al. NATURE REVIEWS DRUG DISCOVERY
- SCRIPDB: a portal for easy access to syntheses, chemicals and reactions in patents
- (2011) A. Heifets et al. NUCLEIC ACIDS RESEARCH
- ChEMBL: a large-scale bioactivity database for drug discovery
- (2011) A. Gaulton et al. NUCLEIC ACIDS RESEARCH
- Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffolds
- (2011) Christopher Southan et al. Journal of Cheminformatics
- The Drug Discovery Portal: a resource to enhance drug discovery from academia
- (2010) Rachel L. Clark et al. DRUG DISCOVERY TODAY
- The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor
- (2010) Elisabeth Perzborn et al. NATURE REVIEWS DRUG DISCOVERY
- Improving Compound Quality throughin vitroandin silicoPhysicochemical Profiling
- (2009) Han vanâ deâ Waterbeemd CHEMISTRY & BIODIVERSITY
- The genetics of a pharma merger
- (2009) Philippe Sanseau et al. DRUG DISCOVERY TODAY
- Lowering industry firewalls: pre-competitive informatics initiatives in drug discovery
- (2009) Michael R. Barnes et al. NATURE REVIEWS DRUG DISCOVERY
- Lessons from 60 years of pharmaceutical innovation
- (2009) Bernard Munos NATURE REVIEWS DRUG DISCOVERY
- Can literature analysis identify innovation drivers in drug discovery?
- (2009) Pankaj Agarwal et al. NATURE REVIEWS DRUG DISCOVERY
- Quantitative assessment of the expanding complementarity between public and commercial databases of bioactive compounds
- (2009) Christopher Southan et al. Journal of Cheminformatics
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More